Clinical Trials Directory

Trials / Completed

CompletedNCT00406289

Trial of Adaptive 18F-FDG-PET Biological Intensity-modulated Radiotherapy (BG-IMRT) in Patients With Head and Neck Tumor

Phase I Trial of Adaptive 18F-FDG-PET Biological Intensity-modulated Radiotherapy (BG-IMRT) With Patients With Head and Neck Tumor

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
24 (estimated)
Sponsor
University Hospital, Ghent · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study will evaluate the feasibility of higher and prolonged dose escalation concentrated in the intra-tumoral regions which are FDG-avid after two weeks of radiotherapy.

Conditions

Interventions

TypeNameDescription
PROCEDURE18F-FDG-PET radiotherapy

Timeline

Start date
2006-11-01
Primary completion
2009-08-01
Completion
2010-02-01
First posted
2006-12-04
Last updated
2010-09-06

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT00406289. Inclusion in this directory is not an endorsement.

Trial of Adaptive 18F-FDG-PET Biological Intensity-modulated Radiotherapy (BG-IMRT) in Patients With Head and Neck Tumor (NCT00406289) · Clinical Trials Directory